As the calculation of BREGRS relied on mRNA expression levels, we proceeded to perform RT-qPCR experiments to measure the mRNA levels of CD96, OAS1, and CSH1 in 34 BLCA samples obtained from our local hospital (Fig. 6A). The gene discussed is CD96; the disease is bladder transitional cell carcinoma.